http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101249225-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7032 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02 |
| filingDate | 2006-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101249225-B1 |
| titleOfInvention | How to inhibit and / or treat a vaginal infection |
| abstract | The present invention provides methods for inhibiting and / or treating vaginal infections. The method includes exposing one or more microorganisms to a therapeutic composition. Microorganism is Pasteurella pure gold (Gardnerella), is selected from the group consisting of Candida (Candida), and trichomonas (Trichomonas) teaches, treatment composition an effective amount of a saccharide-based and a non-ionic surfactant. For example, in one embodiment the saccharide-based nonionic surfactant is an alkyl glycoside.n n n Saccharide-based nonionic surfactants, vaginal infections, Gardnerella vaginalis, Candida albicans, trichomonas vaginalis, alkyl glycosides |
| priorityDate | 2005-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 229.